Peter N. Pferschy

998 total citations
27 papers, 307 citations indexed

About

Peter N. Pferschy is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Peter N. Pferschy has authored 27 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Physiology and 8 papers in Surgery. Recurrent topics in Peter N. Pferschy's work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (10 papers) and Diet and metabolism studies (9 papers). Peter N. Pferschy is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes Treatment and Management (10 papers) and Diet and metabolism studies (9 papers). Peter N. Pferschy collaborates with scholars based in Austria, Germany and United Arab Emirates. Peter N. Pferschy's co-authors include Harald Sourij, Norbert J. Tripolt, Caren Sourij, Felix Aberer, Harald Kojzar, Faisal Aziz, Max L. Eckstein, Othmar Moser, Abderrahim Oulhaj and Dirk von Lewinski and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Peter N. Pferschy

26 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter N. Pferschy Austria	11	182	113	80	61	55	27	307
Caren Sourij Austria	10	146 0.8×	90 0.8×	72 0.9×	57 0.9×	33 0.6×	30	265
Christophe Kosinski Switzerland	7	142 0.8×	192 1.7×	42 0.5×	24 0.4×	55 1.0×	21	315
Medini Reddy-Luthmoodoo Australia	7	81 0.4×	152 1.3×	64 0.8×	12 0.2×	87 1.6×	8	327
Imad Brema Saudi Arabia	8	103 0.6×	105 0.9×	36 0.5×	17 0.3×	118 2.1×	20	314
Viviana A. Ruiz‐Pozo Ecuador	10	47 0.3×	77 0.7×	28 0.3×	25 0.4×	92 1.7×	36	263
Elius Paz‐Cruz Ecuador	10	47 0.3×	71 0.6×	25 0.3×	26 0.4×	90 1.6×	35	252
José-Miguel González-Clemente Spain	11	146 0.8×	49 0.4×	49 0.6×	61 1.0×	51 0.9×	19	353
Ehsan Parvaresh Rizi Singapore	12	130 0.7×	71 0.6×	44 0.6×	32 0.5×	40 0.7×	20	291
Hongrong Deng China	11	177 1.0×	58 0.5×	88 1.1×	86 1.4×	55 1.0×	42	317
Arlette Soros United States	8	218 1.2×	68 0.6×	47 0.6×	50 0.8×	38 0.7×	14	333

Countries citing papers authored by Peter N. Pferschy

Since Specialization

Citations

This map shows the geographic impact of Peter N. Pferschy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. Pferschy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. Pferschy more than expected).

Fields of papers citing papers by Peter N. Pferschy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N. Pferschy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. Pferschy. The network helps show where Peter N. Pferschy may publish in the future.

Co-authorship network of co-authors of Peter N. Pferschy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter N. Pferschy. A scholar is included among the top collaborators of Peter N. Pferschy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter N. Pferschy. Peter N. Pferschy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tripolt, Norbert J., Peter N. Pferschy, Harald Kojzar, et al.. (2026). Impact of intermittent fasting on self‐regulatory behaviour and sleep in participants with insulin‐treated type 2 diabetes: A secondary analysis of the INTERFAST‐2 randomised controlled trial. Diabetes Obesity and Metabolism. 28(4). 3415–3419.

Benedikt, Martin, Faisal Aziz, Ewald Kolesnik, et al.. (2024). Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin. Scientific Reports. 14(1). 15083–15083. 1 indexed citations

Aziz, Faisal, Norbert J. Tripolt, Peter N. Pferschy, et al.. (2024). Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial. Cardiovascular Diabetology. 23(1). 145–145. 10 indexed citations

Pferschy, Peter N., Norbert J. Tripolt, Hansjörg Habisch, et al.. (2024). Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial. Cardiovascular Diabetology. 23(1). 339–339. 4 indexed citations

Lewinski, Dirk von, Ewald Kolesnik, Faisal Aziz, et al.. (2023). Timing of SGLT2i initiation after acute myocardial infarction. Cardiovascular Diabetology. 22(1). 269–269. 12 indexed citations

Benedikt, Martin, Harald Mangge, Faisal Aziz, et al.. (2023). Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial. Cardiovascular Diabetology. 22(1). 166–166. 21 indexed citations

Aziz, Faisal, Norbert J. Tripolt, Peter N. Pferschy, et al.. (2023). Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial. Cardiovascular Diabetology. 22(1). 184–184. 11 indexed citations

Sourij, Caren, Faisal Aziz, Norbert J. Tripolt, et al.. (2023). Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trial. Hellenic Journal of Cardiology. 75. 3–8. 7 indexed citations

Eyileten, Ceren, Zofia Wicik, Faisal Aziz, et al.. (2022). Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study. Cardiovascular Diabetology. 21(1). 79–79. 15 indexed citations

10.

Moser, Othmar, Alexander Müller, Felix Aberer, et al.. (2022). Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study). Diabetes Technology & Therapeutics. 25(3). 161–168. 7 indexed citations

11.

Tripolt, Norbert J., Peter N. Pferschy, Harald Kojzar, et al.. (2022). Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial. Diabetes Care. 46(2). 463–468. 51 indexed citations

12.

Moser, Othmar, Max L. Eckstein, Alexander Mueller, et al.. (2021). Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial. Frontiers in Endocrinology. 12. 656346–656346. 9 indexed citations

13.

Aberer, Felix, Othmar Moser, Faisal Aziz, et al.. (2021). Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study. Diabetes Care. 45(2). e24–e26. 20 indexed citations

14.

Tripolt, Norbert J., Faisal Aziz, Christoph Högenauer, et al.. (2021). EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus. Biomolecules. 11(4). 574–574. 7 indexed citations

15.

Moser, Othmar, Alexander Mueller, Max L. Eckstein, et al.. (2020). Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study. PLoS ONE. 15(9). e0239091–e0239091. 7 indexed citations

16.

Eckstein, Max L., Norbert J. Tripolt, Alexander Müller, et al.. (2020). Efficacy of Carbohydrate Supplementation Compared With Bolus Insulin Dose Reduction Around Exercise in Adults With Type 1 Diabetes: A Retrospective, Controlled Analysis. Canadian Journal of Diabetes. 44(8). 697–700. 3 indexed citations

17.

Aberer, Felix, Peter N. Pferschy, Norbert J. Tripolt, et al.. (2019). Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study. Diabetes Obesity and Metabolism. 22(2). 212–221. 10 indexed citations

18.

Tripolt, Norbert J., Felix Aberer, Jasmin Url, et al.. (2018). Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial. Diabetes Therapy. 10(1). 299–309. 4 indexed citations

19.

Aberer, Felix, Julia K. Mader, Christian Trummer, et al.. (2018). Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trial. Journal of Diabetes Investigation. 10(2). 339–342. 6 indexed citations

20.

Tripolt, Norbert J., Slaven Stekovic, Felix Aberer, et al.. (2018). Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial. Advances in Therapy. 35(8). 1265–1283. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact